- Sponsor: National Institutes of Health (NIH)
- Internal Deadline: January 10, 2020
- Sponsor LOI Deadline: February 3, 2020
- Sponsor Deadline: March 3, 2020
- Link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-19-068.html
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Immune Tolerance Network. The major goal of this Network is to develop tolerogenic approaches for the treatment and prevention of disease in three clinical areas: asthma and allergic diseases; autoimmune diseases; and immune-mediated consequences of allotransplantation. The scope of research to be carried out includes: 1) the design and conduct of clinical trials at all phases to evaluate the safety and efficacy of investigational products and approaches for the induction and maintenance of immune tolerance in humans, 2) the design and conduct of mechanistic studies and the development of tolerance assays as integral components of the clinical trials undertaken, including establishing and directing a consortium of laboratories and one or more biospecimen repositories, and 3) the provision of bioinformatics, data collection, validation and analysis resources. In addition, on a limited basis, the Network may support focused product development and nonclinical studies (e.g., toxicology, pharmacology, pharmacokinetics, etc.) essential for the subsequent evaluation of promising tolerance induction approaches in humans.
Please read the full program announcement before preparing your internal application.
- NIAID intends to commit $27 million in FY 2021 to fund 1 award.
- Recommended application budgets are limited to $23 million per year in direct costs.
- The proposed project period must be 7 years.
- Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
Detailed review criteria can be found here.
An Institution may submit one proposal.
If you are interested in submitting for this program, you must first submit an internal application to firstname.lastname@example.org according to the required instructions below.
Internal Applications must include the following:
- A cover page listing
- The name of this funding opportunity and title of your proposal
- Your name, UGA position, home department, email, and UGA contact information
- Collaborator names, positions, and institutions (if any)
- Indicate whether or not you have submitted to this program in the past. If so, please provide a copy of the review at the end of the internal application.
- A (maximum two-page) proposal summary that addresses the program’s specific selection criteria.
- One paragraph describing why this proposal should be UGA’s submission (i.e., why it will be the most competitive for this program)
- A two-page Curriculum vitae
Limited Submission announcements often generate multiple competing proposals. UGA reviewers judge proposals as they would in any peer review process, so PIs are urged to put their best foot forward. Along with typical criteria, reviewers will evaluate internal proposals based on their fit with the sponsor’s articulated goals and criteria.
Internal Submission Instructions
The above internal application materials should be submitted via email as a single .PDF file to email@example.com by the internal deadline listed above.
Please submit questions regarding the internal competition to firstname.lastname@example.org.
For questions directly related to this program, please contact the following program officers:
National Institute of Allergy and Infectious Diseases (NIAID)
View our calendar for all Current and Closed Limited
Subscribe to our listerv to receive weekly internal competition announcements.
What is a Limited Submission?